October 2021 // Company

Synendos Therapeutics Appoints Scientific Advisory Board


Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board composed of prominent scientists and clinicians with significant CNS expertise.


Download here below the full press release.



Synendos Press Release October 2021
.pdf
Download PDF • 249KB




Recent Posts

See All

Synendos Therapeutics has been awarded with the Innosuisse Certificate Synendos has been awarded the Innosuisse certificate by Innosuisse Innovation Council. The Innosuisse certificate reflects remark

Synendos Therapeutics is ranked TOP 100 Swiss Startups 2022 We are honored to be listed for the second year in a row as one of the TOP 100 Swiss Startups 2022. A big thank you to our team, partners, c